BAC

DRUG3 trials

Sponsors

Charsire Biotechnology Corp., Changhai Hospital, Radboud Universitair Medisch Centrum

Conditions

Alzheimer's DiseaseHIVPancreatic DiseasesVascular Dementia

Phase 2

BAC in Patient With Alzheimer's Disease or Vascular Dementia

WithdrawnNCT02467413

Charsire Biotechnology Corp.Alzheimer's Disease, Vascular Dementia

Start: 2017-01-30End: 2018-11-01Updated: 2022-10-07

Unknown Phase

Relative bioavailability study to investigate a potential interaction between dolutegravir (DTG) and tenofovir alafenamide fumarate/emtricitabine (F/TAF) administered as paediatric tablet formulations.

Active, not recruitingNL-OMON51616

Radboud Universitair Medisch CentrumHIV

Start: 2022-11-02Target: 16Updated: 2024-04-15

The 22G Franseen Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy

Not yet recruitingNCT07023549

Changhai HospitalPancreatic Diseases

Start: 2025-07-01End: 2027-05-31Target: 270Updated: 2025-06-17